Sequenom Soaring on Wedbush Upgrade

Shares of small-cap biotech firm Sequenom are soaring on Tuesday after pulling back during Monday's trading session. The stock was upgraded at Wedbush from Underperform to Neutral this morning. The investment company also raised their price target on the stock from $3.00 to $5.00. SQNM shares have soared 9.23% to $5.09 in the wake of the news. Over the last month, the stock has added nearly 27%. The name has a very high short interest with roughly 21% of the float sold short, and these short sellers could continue to drive the stock higher on Tuesday. Sequenom, Inc. (Sequenom) is a diagnostic testing and genetics analysis company.